{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T17:29:24Z","timestamp":1655400564294},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s11938-005-0026-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T13:48:40Z","timestamp":1180878520000},"page":"325-336","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of functional dyspepsia"],"prefix":"10.1007","volume":"8","author":[{"given":"Smita L. S.","family":"Halder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(05)70362-9","volume":"25","author":"GR Locke 3rd","year":"1996","unstructured":"Locke GR, 3rd: The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996, 25: 1\u201319.","journal-title":"Gastroenterol Clin North Am"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2165\/00019053-199201050-00003","volume":"1","author":"O Nyren","year":"1992","unstructured":"Nyren O, Lindberg G, Lindstrom E, et al.: Economic costs of functional dyspepsia. Pharmacoeconomics 1992, 1: 312\u2013324.","journal-title":"Pharmacoeconomics"},{"issue":"Suppl 4","key":"26_CR3","first-page":"iv10","volume":"50","author":"P Moayyedi","year":"2002","unstructured":"Moayyedi P, Mason J: Clinical and economic consequences of dyspepsia in the community. Gut 2002, 50(Suppl 4):iv10-iv12.","journal-title":"Gut"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V Stanghellini","year":"1996","unstructured":"Stanghellini V, Tosetti C, Paternic A, et al.: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110: 1036\u20131042.","journal-title":"Gastroenterology"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","volume":"121","author":"J Tack","year":"2001","unstructured":"Tack J, Caenepeel P, Fischler B, et al.: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001, 121: 526\u2013535.","journal-title":"Gastroenterology"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0016-5085(99)70171-X","volume":"116","author":"M Samsom","year":"1999","unstructured":"Samsom M, Verhagen MA, van Berge Henegouwen GP, et al.: Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999, 116: 515\u2013520.","journal-title":"Gastroenterology"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","volume":"126","author":"G Holtmann","year":"2004","unstructured":"Holtmann G, Siffert W, Haag S, et al.: G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004, 126: 971\u2013979.","journal-title":"Gastroenterology"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","volume":"114","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Silverstein MD, Agreus L, et al.: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998, 114: 582\u2013595.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"26_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2036.2002.0160s1058.x","volume":"16","author":"NJ Talley","year":"2002","unstructured":"Talley NJ, Quan C: Review article: Helicobacter pylori and nonulcer dyspepsia. Aliment Pharmacol Ther 2002, 16(Suppl 1):58\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR10","first-page":"CD002096","volume":"1","author":"P Moayyedi","year":"2005","unstructured":"MoayyediP, Soo S, Deeks J, et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005, 1: CD002096. The most comprehensive systematic review on this controversial subject. Updated regularly.","journal-title":"Cochrane Database Syst Rev"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","volume":"324","author":"N Chiba","year":"2002","unstructured":"Chiba N, Van Zanten SJ, Sinclair P, et al.: Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.[see comment]. BMJ 2002, 324: 1012\u20131016.","journal-title":"BMJ"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00365520310008674","volume":"39","author":"M Farkkila","year":"2004","unstructured":"Farkkila M, Sarna S, Valtonen V, et al.: Does the \u2018test-and-treat\u2019 strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients. Scandinavian Journal of Gastroenterology 2004, 39: 327\u2013335.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P Moayyedi","year":"2004","unstructured":"Moayyedi P, Delaney BC, Vakil N, et al.: The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 2004, 127: 1329\u20131337.","journal-title":"Gastroenterology"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1365-2036.2003.01575.x","volume":"17","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003, 17: 1215\u20131227. Useful overview of the merits of current pharmacological treatments for dyspepsia. Treatments are evaluated in comparison to each other as well as placebo.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2036.1992.tb00265.x","volume":"6","author":"M Tatsuta","year":"1992","unstructured":"Tatsuta M, Iishi H, Nakaizumi A, et al.: Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1992, 6: 221\u2013228.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/gut.28.3.300","volume":"28","author":"R Corinaldesi","year":"1987","unstructured":"Corinaldesi R, Stanghellini V, Raiti C, et al.: Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987, 28: 300\u2013305.","journal-title":"Gut"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2036.1995.tb00364.x","volume":"9","author":"JE Kellow","year":"1995","unstructured":"Kellow JE, Cowan H, Shuter B, et al.: Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995, 9: 153\u2013160.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"26_CR18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"TackJ, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004, 127(4):1239\u20131255. Excellent overview of the current theories behind the mechanisms of functional dyspepisa.","journal-title":"Gastroenterology"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00365528809093840","volume":"23","author":"R Gotthard","year":"1988","unstructured":"Gotthard R, Bodemar G, Brodin U, et al.: Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988, 23: 7\u201318.","journal-title":"Scand J Gastroenterol"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJM198602063140603","volume":"314","author":"O Nyren","year":"1986","unstructured":"Nyren O, Adami HO, Bates S, et al.: Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986, 314: 339\u2013343.","journal-title":"N Engl J Med"},{"key":"26_CR21","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2004:CD001960.","DOI":"10.1002\/14651858.CD001960.pub2"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-3999(94)90033-7","volume":"38","author":"TT Haug","year":"1994","unstructured":"Haug TT, Svebak S, Wilhelmsen I, et al.: Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res 1994, 38: 281\u2013291.","journal-title":"J Psychosom Res"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0016-5085(86)90864-4","volume":"90","author":"NJ Talley","year":"1986","unstructured":"Talley NJ, Fung LH, Gilligan IJ, et al.: Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology 1986, 90: 886\u2013892.","journal-title":"Gastroenterology"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00006842-199405000-00001","volume":"56","author":"TT Haug","year":"1994","unstructured":"Haug TT, Svebak S, Hausken T, et al.: Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 1994, 56: 181\u2013186.","journal-title":"Psychosom Med"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00004836-200403000-00007","volume":"38","author":"SL Lorena","year":"2004","unstructured":"Lorena SL, Tinois E, Brunetto SQ, et al.: Gastric emptying and intragastric distribution of a solid meal in functional dyspepsia: influence of gender and anxiety. J Clin Gastroenterol 2004, 38: 230\u2013236.","journal-title":"J Clin Gastroenterol"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/BF01296514","volume":"31","author":"M Camilleri","year":"1986","unstructured":"Camilleri M, Malagelada JR, Kao PC, et al.: Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci 1986, 31: 1169\u20131177.","journal-title":"Dig Dis Sci"},{"key":"26_CR27","doi-asserted-by":"crossref","unstructured":"Soo S, Moayyedi P, Deeks J, et al.: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2004:CD002301.","DOI":"10.1002\/14651858.CD002301.pub2"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-3999(94)90026-4","volume":"38","author":"TT Haug","year":"1994","unstructured":"Haug TT, Wilhelmsen I, Svebak S, et al.: Psychotherapy in functional dyspepsia. J Psychosom Res 1994, 38: 735\u2013744.","journal-title":"J Psychosom Res"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J Hamilton","year":"2000","unstructured":"Hamilton J, Guthrie E, Creed F, et al.: A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000, 119: 661\u2013669.","journal-title":"Gastroenterology"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert EL, Houghton LA, Cooper P, et al.: Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002, 123: 1778\u20131785.","journal-title":"Gastroenterology"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/16506078809456271","volume":"17","author":"S Bates","year":"1988","unstructured":"Bates S, Sjoden PO, Nyren O: Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988, 17: 155\u2013165.","journal-title":"Scand J Behav Ther"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"JL Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108: 65\u201372.","journal-title":"Am J Med"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634443","volume":"99","author":"D Loldrup","year":"1989","unstructured":"Loldrup D, Langemark M, Hansen HJ, et al.: Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology (Berl) 1989, 99: 1\u20137.","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"26_CR34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A, et al.: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 93(2):160\u2013165.","journal-title":"Am J Gastroenterol"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","volume":"17","author":"J Tack","year":"2003","unstructured":"Tack J, Broekaert D, Coulie B, et al.: Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 2003, 17: 603\u2013608.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR36","first-page":"42","volume":"11","author":"HA Tindle","year":"2005","unstructured":"Tindle HA, Davis RB, Phillips RS, et al.: Trends in use of complementary and alternative medicine by US adults: 1997\u20132002. Altern Ther Health Med 2005, 11: 42\u201349.","journal-title":"Altern Ther Health Med"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1046\/j.1365-2036.2003.01767.x","volume":"18","author":"G Holtmann","year":"2003","unstructured":"Holtmann G, Adam B, Haag S, et al.: Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebocontrolled, double-blind, multicentre trial. Aliment Pharmacol Ther 2003, 18: 1099\u20131105.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1046\/j.1365-2036.2002.01339.x","volume":"16","author":"J Thompson Coon","year":"2002","unstructured":"Thompson Coon J, Ernst E: Herbal medicinal products for non-ulcer dyspepsia. Aliment Pharmacol Ther 2002, 16: 1689\u20131699.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","volume":"20","author":"J Melzer","year":"2004","unstructured":"Melzer J, Rosch W, Reichling J, et al.: Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 2004, 20: 1279\u20131287.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115: 1346\u20131352.","journal-title":"Gastroenterology"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gut.42.6.814","volume":"42","author":"H Mertz","year":"1998","unstructured":"Mertz H, Fullerton S, Naliboff B, et al.: Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998, 42: 814\u2013822.","journal-title":"Gut"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.46.4.468","volume":"46","author":"J Tack","year":"2000","unstructured":"Tack J, Coulie B, Wilmer A, et al.: Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000, 46: 468\u2013473.","journal-title":"Gut"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2004.07.005","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack J, Caenepeel P, Corsetti M, et al.: Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004, 127: 1058\u20131066.","journal-title":"Gastroenterology"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","volume":"13","author":"M Camilleri","year":"1999","unstructured":"Camilleri M, Mayer EA, Drossman DA, et al.: Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999, 13: 1149\u20131159.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15: 525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5085(99)70226-X","volume":"116","author":"M Delvaux","year":"1999","unstructured":"Delvaux M, Louvel D, Lagier E, et al.: The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 1999, 116: 38\u201345.","journal-title":"Gastroenterology"},{"key":"26_CR47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"NW Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41: 664\u2013668.","journal-title":"Gut"},{"key":"26_CR48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/BF02087560","volume":"39","author":"B Fraitag","year":"1994","unstructured":"Fraitag B, Homerin M, Hecketsweiler P: Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci 1994, 39: 1072\u20131077.","journal-title":"Dig Dis Sci"},{"key":"26_CR49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2036.2003.01670.x","volume":"18","author":"S Delgado-Aros","year":"2003","unstructured":"Delgado-Aros S, Chial HJ, Cremonini F, et al.: Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther 2003, 18: 507\u2013514.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.2000.00742.x","volume":"14","author":"C Mansi","year":"2000","unstructured":"Mansi C, Borro P, Giacomini M, et al.: Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000, 14: 561\u2013569.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2036.2002.01180.x","volume":"16","author":"E Distrutti","year":"2002","unstructured":"Distrutti E, Fiorucci S, Hauer SK, et al.: Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther 2002, 16: 613\u2013622.","journal-title":"Aliment Pharmacol Ther"},{"key":"26_CR52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1542-3565(04)00059-X","volume":"2","author":"F Mearin","year":"2004","unstructured":"Mearin F, Rodrigo L, Perez-Mota A, et al.: Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004, 2: 301\u2013308.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"26_CR53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.102.048603","volume":"306","author":"T Tsubouchi","year":"2003","unstructured":"Tsubouchi T, Saito T, Mizutani F, et al.: Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo. J Pharmacol Exp Ther 2003, 306: 787\u2013793. Epub 2003 Apr 30.","journal-title":"J Pharmacol Exp Ther"},{"key":"26_CR54","doi-asserted-by":"crossref","first-page":"A","DOI":"10.1053\/j.gastro.2004.01.006","volume":"126","author":"G Holtmann","year":"2004","unstructured":"Holtmann G, Schnittker J, Boos G, et al.: A randomized, double-blind, placebo-controlled dose finding study of Itopride for the treatment of patients with funcitonal dyspepsia. Gastroenterology 2004, 126: A-100.","journal-title":"Gastroenterology"},{"key":"26_CR55","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.2000.278.5.R1217","volume":"278","author":"C Feinle","year":"2000","unstructured":"Feinle C, Grundy D, Otto B, et al.: Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Comp Physiol 2000, 278: R1217-R1223.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"26_CR56","doi-asserted-by":"crossref","first-page":"G183","DOI":"10.1152\/ajpgi.00434.2003","volume":"286","author":"TH Moran","year":"2004","unstructured":"Moran TH, Kinzig KP: Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004, 286: G183-G188.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"26_CR57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","volume":"48","author":"C Feinle","year":"2001","unstructured":"Feinle C, Meier O, Otto B, et al.: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48: 347\u2013355.","journal-title":"Gut"},{"key":"26_CR58","first-page":"621","volume":"3","author":"G Varga","year":"2002","unstructured":"Varga G: Dexloxiglumide Rotta Research Lab. Curr Opin Investig Drugs 2002, 3: 621\u2013626.","journal-title":"Curr Opin Investig Drugs"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-005-0026-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-005-0026-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-005-0026-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:57:01Z","timestamp":1559422621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-005-0026-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11938-005-0026-8","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}